EE173 Economic Evaluation of Exagamglogene Autotemcel (EXA-CEL) Gene-Edited Therapy in Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive CrisesC. Udeze, A. Lopez, F.J. Ogunsile et al.|Value in Health|2023Cited by 3